Leveraging RWE to Drive Patient Access
in the age of Big Data Analytics
11:00 am – 12:00 pm EST
March 5th, 2019
Why is RWE gaining increasing importance not just from a payer perspective but also from a regulatory perspective?
The FDAs new strategic framework to advance the use of RWE to support the development of drugs and biologics has recently been issued. This reinforces the fact that there is an ever growing interest to not only generate real world evidence but also demonstrate value to relevant stakeholders involved in the patient access decision making process. New age healthcare apps and digital therapeutics are also gaining traction, and real world evidence is critical in measuring the impact of these interventions on health outcomes.
This webinar will showcase how RWE and data analytics can be leveraged for evidence generation and value demonstration. Leading industry SMEs and speakers will provide their unique perspectives on the topic and discuss how life sciences organization are securely and efficiently driving their real world evidence initiatives.
- Generating and Harnessing Real-world Evidence in the Era of Big Data
- Immuno-oncology, Survival Modeling and Nice Assessment: Get Ahead of the Curve
- How to collect RWE to show an App Increases Patient Engagement & Improves Outcomes
REGISTRATION DOES NOT GUARANTEE ACCEPTANCE TO ATTEND THIS WEBINAR. ALL REGISTRATIONS WILL BE REVIEWED BY SPONSORING COMPANY WITHIN 48 HOURS OF RECEIPT. HEALTHECONOMICS.COM DOES NOT APPROVE OR DENY ANY REGISTRATIONS. THIS RESPONSIBILITY IS HELD SOLELY BY THE SPONSORING ORGANIZATION.
Kelly Zou, Ph.D., Pstat
Topic: Generating and Harnessing Real-world Evidence in the Era of Big Data
Murvin Joontun, MSc – Consultant
Topic: Immuno-oncology, Survival Modeling and Nice Assessment: Get Ahead of the Curve
Swatee Surve, Founder & CEO
Topic: How to collect RWE to show an App Increases Patient Engagement & Improves Outcomes